Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 267
Filter
Add more filters










Publication year range
2.
Biochemistry ; 40(36): 10846-52, 2001 Sep 11.
Article in English | MEDLINE | ID: mdl-11535061

ABSTRACT

Arfophilin was first identified as a target protein for GTP-ARF5. The N-terminus of ARF5 (amino acids 2-17), which is distinct from that of class I or class III ARFs, is essential for binding to the C-terminus of arfophilin (amino acids 612-756). This study using GST fusion proteins in pulldown experiments in CHO-K1 cell lysates showed that, unexpectedly, ARF6 also bound to full-length arfophilin or the C-terminus of arfophilin (amino acids 612-756) in a GTP-dependent manner. Studies with ARF1/ARF6 chimeras further showed that the amino acid sequence of residues 37-80 of ARF6, which is different from the corresponding sequences in class I and class II ARFs, was essential for binding to arfophilin. Both GTP-ARF5 and GTP-ARF6 bound to arfophilin in CHO-K1 cell lysates, while GTP-ARF1 did not bind. In contrast, all three forms of ARF bound to arfaptin 2, with ARF1 showing the strongest binding. Yeast two-hybrid studies with wild-type, dominant negative, and constitutively active forms of ARF1, -5, and -6 and with ARF1/ARF6 chimeras confirmed these results, except that constitutively active ARF6 was autoactivating. Our findings suggest that both class II and III ARFs may influence the same cellular pathways through arfophilin as a common downstream effector.


Subject(s)
ADP-Ribosylation Factors/chemistry , ADP-Ribosylation Factors/metabolism , Carrier Proteins/metabolism , ADP-Ribosylation Factor 1/chemistry , ADP-Ribosylation Factor 6 , Amino Acid Sequence , Amino Acid Substitution , Animals , Binding Sites , CHO Cells , Cloning, Molecular , Cricetinae , Escherichia coli , Glutathione Transferase/metabolism , Guanosine Triphosphate/metabolism , Molecular Sequence Data , Mutagenesis, Site-Directed , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Transfection
3.
Biochem Biophys Res Commun ; 285(5): 1267-73, 2001 Aug 03.
Article in English | MEDLINE | ID: mdl-11478794

ABSTRACT

We first identified arfaptin as a protein that bound to GTP-ARFs (especially ARF1). However, a second group reported that POR1, a truncated form of arfaptin, bound to GTP-Rac1. Therefore, we examined the possibility that arfaptin 2/POR1 was a common downstream effector for both ARF1 and Rac1. In this study, we found that constitutively active Rac1 or GTP-Rac1 showed negligible or no binding to arfaptin 2/POR1 in a yeast two-hybrid assay or a GST pull-down assay. However, wild-type or dominant negative Rac1 or Rac1 liganded to GDP showed strong binding. In contrast, constitutively active ARFs1, 5, and 6 showed binding, whereas the wild-type and dominant negative forms did not. Furthermore, the GTP-liganded ARFs bound arfaptin 2, whereas the GDP-bound forms showed little or no binding. Based on these observations, we suggest that arfaptin 2/POR1 is a target protein for GTP-ARFs and for GDP-Rac1, and that it may be involved in interactions between the Rac and ARF signaling pathways.


Subject(s)
ADP-Ribosylation Factors/metabolism , Adaptor Proteins, Signal Transducing , Carrier Proteins/metabolism , rac1 GTP-Binding Protein/metabolism , ADP-Ribosylation Factors/genetics , Animals , Base Sequence , Blotting, Western , CHO Cells , Carrier Proteins/genetics , Cricetinae , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , Gene Expression , Genes, Dominant , Glutathione Transferase/genetics , Glutathione Transferase/metabolism , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Guanosine Diphosphate/metabolism , Humans , Molecular Sequence Data , Mutagenesis , Protein Binding/drug effects , Protein Binding/physiology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Transfection , Two-Hybrid System Techniques , rac1 GTP-Binding Protein/genetics
4.
Mol Cell Biol ; 21(12): 4055-66, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11359912

ABSTRACT

Phospholipase D (PLD) is a ubiquitously expressed enzyme of ill-defined function. In order to explore its cellular actions, we inactivated the rat PLD1 (rPLD1) isozyme by tagging its C terminus with a V5 epitope (rPLD1-V5). This was stably expressed in Rat-2 fibroblasts to see if it acted as a dominant-negative mutant for PLD activity. Three clones that expressed rPLD1-V5 were selected (Rat2V16, Rat2V25, and Rat2V29). Another clone (Rat2V20) that lost expression of rPLD1-V5 was also obtained. In the three clones expressing rPLD1-V5, PLD activity stimulated by phorbol myristate acetate (PMA) or lysophosphatidic acid (LPA) was reduced by ~50%, while the PLD activity of Rat2V20 cells was normal. Changes in the actin cytoskeleton in response to LPA or PMA were examined in these clones. All three clones expressing rPLD1-V5 failed to form actin stress fibers after treatment with LPA. However, Rat2V20 cells formed stress fibers in response to LPA to the same extent as wild-type Rat-2 cells. In contrast, there was no significant change in membrane ruffling induced by PMA in the cells expressing rPLD1-V5. Since Rho is an activator both of rPLD1 and stress fiber formation, the activation of Rho was monitored in wild-type Rat-2 cells and Rat2V25 cells, but no significant difference was detected. The phosphorylation of vimentin mediated by Rho-kinase was also intact in Rat2V25 cells. Rat2V25 cells also showed normal vinculin-containing focal adhesions. However, the translocation of alpha-actinin to the cytoplasm and to the detergent-insoluble fraction in Rat2V25 cells was reduced. These results indicate that PLD activity is required for LPA-induced rearrangement of the actin cytoskeleton to form stress fibers and that PLD might be involved in the cross-linking of actin filaments mediated by alpha-actinin.


Subject(s)
Actins/biosynthesis , Phospholipase D/metabolism , Actinin/metabolism , Amino Acid Sequence , Animals , COS Cells , Cell Line , Cytoskeleton/metabolism , Fibroblasts/metabolism , Intracellular Signaling Peptides and Proteins , Isoenzymes/genetics , Isoenzymes/metabolism , Lysophospholipids/pharmacology , Phospholipase D/genetics , Protein Serine-Threonine Kinases/metabolism , Rats , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Tagged Sites , Tetradecanoylphorbol Acetate/pharmacology , Vimentin/metabolism , Vinculin/metabolism , rho GTP-Binding Proteins/metabolism , rho-Associated Kinases
5.
Biochem J ; 355(Pt 3): 779-85, 2001 May 01.
Article in English | MEDLINE | ID: mdl-11311142

ABSTRACT

Phospholipase D (PLD) is regulated by many factors, including protein kinase C (PKC) and small G-proteins of the Rho and ADP-ribosylation factor families. Previous studies revealed that the interaction site of human PLD(1) for RhoA is located in its C-terminus, but the exact locus has not been determined. The purpose of the present study was to determine the interaction site of rat PLD(1) (rPLD(1)) with RhoA. Selection with phage display of different peptides of rPLD(1) confirmed that GTP-bound RhoA interacted with a site in the amino acid sequence 873-1024 at the C-terminus of rPLD(1). RhoA also associated with this peptide in a GTP-dependent manner in COS-7 cell lysates and the peptide inhibited RhoA stimulation of PLD activity in membranes from COS-7 cells expressing rPLD(1). A series of alanine mutations of non-conserved residues were made in this sequence, and the enzymes were expressed in COS-7 cells and checked for responses to activation of PKC, which interacts with the N-terminus of PLD(1), and also to the constitutively active V14RhoA. Mutations in the C-terminus of rPLD(1) (K946A, V950A, R955A and K962A) caused partial loss of V14RhoA stimulation, and double mutations (K946A/K962A, K946A/V950A and K962A/V950A) caused an almost total loss. Co-immunoprecipitation studies also showed that the mutated forms of rPLD(1) described above failed to bind V14RhoA compared with wild-type rPLD(1), whereas rPLD(1) with mutations outside the region K946-K962 bound V14RhoA normally. It is concluded that basic amino acids in a restricted C-terminal region of rPLD(1) are important for binding of RhoA and its activation of PLD activity.


Subject(s)
Phospholipase D/metabolism , rhoA GTP-Binding Protein/metabolism , Animals , Binding Sites , Enzyme Activation , Mutation , Peptide Fragments/metabolism , Peptide Library , Phospholipase D/genetics , Protein Kinase C/metabolism , Rats , rhoA GTP-Binding Protein/genetics
6.
J Biol Chem ; 276(12): 9383-91, 2001 Mar 23.
Article in English | MEDLINE | ID: mdl-11121416

ABSTRACT

Rat brain phospholipase D1 (rPLD1) has two highly conserved motifs (HXKX(4)D), denoted HKD, located in the N- and C-terminal halves, which are required for phospholipase D activity. The two halves of rPLD1 can associate in vivo, and the association is essential for catalytic activity and Ser/Thr phosphorylation of the enzyme. In this study, we found that this association is also required for palmitoylation of rPLD1, which occurs on cysteines 240 and 241. In addition, palmitoylation of rPLD1 requires the N-terminal sequence but not the conserved C-terminal sequence, since rPLD1 that lacks the first 168 amino acids is not palmitoylated in vivo, while the inactive C-terminal deletion mutant is. Palmitoylation of rPLD1 is not necessary for catalytic activity, since N-terminal truncation mutants lacking the first 168 or 319 amino acids exhibit high basal activity although they cannot be stimulated by protein kinase C (PKC). The lack of response to PKC is not due to the lack of palmitoylation, since mutation of both Cys(240) and Cys(241) to alanine in full-length rPLD1 abolishes palmitoylation, but the mutant still retains basal activity and responds to PKC. Palmitoylation-deficient rPLD1 can associate with crude membranes; however, the association is weakened. Wild type rPLD1 remains membrane-associated when extracted with 1 m NaCl or Na(2)CO(3) (pH 11), while rPLD1 mutants that lack palmitoylation are partially released. In addition, we found that palmitoylation-deficient mutants are much less modified by Ser/Thr phosphorylation compared with wild type rPLD1. Characterization of the other cysteine mutations of rPLD1 showed that mutation of cysteine 310 or 612 to alanine increased basal phospholipase D activity 2- and 4-fold, respectively. In summary, palmitoylation of rPLD1 requires interdomain association and the presence of the N-terminal 168 amino acids. Mutations of cysteines 240 and 241 to alanine abolish the extensive Ser/Thr phosphorylation of the enzyme and weaken its association with membranes.


Subject(s)
Palmitic Acid/metabolism , Phospholipase D/metabolism , Animals , Base Sequence , Brain/enzymology , COS Cells , Catalysis , DNA Primers , Mutagenesis, Site-Directed , Phospholipase D/genetics , Phosphorylation , Rats , Serine/metabolism , Threonine/metabolism
7.
Eur J Biochem ; 267(24): 7138-46, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11106425

ABSTRACT

Rat brain phospholipase D1 (rPLD1) has two highly conserved motifs [H(X)K(X)4D, denoted HKD] located at the N-terminal and C-terminal halves, which are required for activity. Association of the two halves is essential for rPLD1 activity, which probably brings the two HKD domains together to form a catalytic center. In the present study, we find that an intact C-terminus is also essential for the catalytic activity of rPLD1. Serial deletion of the last four amino acids, EVWT, which are conserved in all mammalian PLD isoforms, abolished the catalytic activity of rPLD1. This loss of catalytic activity was not due to a lack of association of the N-terminal and C-terminal halves. Mutations of the last three amino acids showed that substitutions with charged or less hydrophobic amino acids all reduced PLD activity. For example, mutations of Thr1036 and Val1034 to Asp or Lys caused marked inactivation, whereas mutation to other amino acids had less effect. Mutation of Trp1035 to Leu, Ala, His or Tyr caused complete inactivation, whereas mutation of Glu1033 to Ala enhanced activity. The size of the amino acids at the C-terminus also affected the catalytic activity of PLD, reduced activity being observed with conservative mutations within the EVWT sequence (such as T/S, V/L or W/F). The enzyme was also inactivated by the addition of Ala or Val to the C-terminus of this sequence. Interestingly, the inactive C-terminal mutants could be complemented by cotransfection with a wild-type C-terminal half to restore PLD activity in vivo. These data demonstrate that the integrity of the C-terminus of rPLD1 is essential for its catalytic activity. Important features are the hydrophobicity, charge and size of the four conserved C-terminal amino acids. It is proposed that these play important roles in maintaining a functional catalytic structure by interacting with a specific domain within rPLD1.


Subject(s)
Amino Acids/metabolism , Phospholipase D/metabolism , Animals , COS Cells , Catalysis , Phospholipase D/chemistry , Rats , Sequence Deletion
8.
Biochem Biophys Res Commun ; 277(3): 718-21, 2000 Nov 02.
Article in English | MEDLINE | ID: mdl-11062019

ABSTRACT

RhoA is a small G protein that is implicated in the regulation of the actin cytoskeleton, gene expression, and cell cycle progression. It is activated by many agonists whose receptors are linked to heterotrimeric G proteins, but the mechanisms are incompletely understood. In this study, we show that the constitutively active alpha-subunit of the heterotrimeric G protein G(13) associated with the Rho family guanine nucleotide exchange factor Dbl in NIH 3T3 cells and that this resulted in activation of RhoA. This activation was not seen with wild-type Galpha(13) or if Dbl and active Galpha(13) were expressed separately and mixed. In contrast, coexpression of constitutively active Galpha(q) with Dbl did not lead to their association and caused a weak activation of RhoA that was no greater than that observed with wild-type Galpha(q). These findings illustrate that activated Galpha(13) and Dbl can associate in vivo and that this leads to Rho activation.


Subject(s)
Heterotrimeric GTP-Binding Proteins/metabolism , Retroviridae Proteins, Oncogenic/metabolism , rhoA GTP-Binding Protein/metabolism , 3T3 Cells , Animals , GTP-Binding Protein alpha Subunits, G12-G13 , GTP-Binding Protein alpha Subunits, Gq-G11 , Guanine Nucleotide Exchange Factors , Mice
9.
J Neurochem ; 75(6): 2445-54, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11080196

ABSTRACT

Phospholipase D2 (PLD2) is expressed in brain and inhibited by synuclein, which is involved in Parkinson's and Alzheimer's diseases. However, the activation mechanism of PLD2 in neuronal cells has not been defined clearly. Hydrogen peroxide (H(2)O(2)) plays roles in the neurodegenerative diseases and also acts as a second messenger of various molecules such as nerve growth factor. To study regulation mechanisms of PLD2 by H(2)O(2) in neuronal cells, we have made stable PC12 cell lines expressing PLD2 (PLD2-PC12 cells). H(2)O(2) treatment stimulated PLD activity in PLD2-PC12 cells in a dose- and time-dependent manner. This activation was inhibited by the treatment with protein kinase C (PKC) inhibitors or by depletion of PKCalpha, -delta, and -epsilon. Phorbol ester markedly activated PLD2. Co-treatment with phorbol ester and H(2)O(2) did not show an additive effect. Chelation of extracellular calcium substantially blocked the H(2)O(2)-induced activation of PLD2. A calcium ionophore induced PLD2 activation in a PKC-dependent manner. Protein-tyrosine kinase inhibitors inhibited H(2)O(2)-induced PLD activation slightly. These data indicate that H(2)O(2) can activate PLD2 in PC12 cells and that this activation is largely dependent on PKC and Ca(2+) ions and minimally dependent on tyrosine phosphorylation.


Subject(s)
Hydrogen Peroxide/metabolism , Neurons/metabolism , Phospholipase D/metabolism , Animals , Calcium/metabolism , Calcium/pharmacology , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacokinetics , Enzyme Inhibitors/pharmacology , Isoenzymes/metabolism , Neurons/cytology , Neurons/drug effects , PC12 Cells , Phosphorylation/drug effects , Protein Kinase C/metabolism , Protein-Tyrosine Kinases/antagonists & inhibitors , Rats , Tetradecanoylphorbol Acetate/pharmacology
10.
J Biol Chem ; 275(32): 24962-9, 2000 Aug 11.
Article in English | MEDLINE | ID: mdl-10825182

ABSTRACT

Rat brain phospholipase D1 (rPLD1) belongs to a superfamily defined by the highly conserved catalytic motif (H(X)K(X)(4)D, denoted HKD. rPLD1 contains two HKD domains, located in the N- and C-terminal regions. The integrity of the two HKD domains is essential for enzymatic activity. Our previous studies showed that the N-terminal half of rPLD1 containing one HKD motif can associate with the C-terminal half containing the other HKD domain to reconstruct wild type PLD activity (Xie, Z., Ho, W.-T. and Exton, J. H. (1998) J. Biol. Chem. 273, 34679-34682). In the present study, we have shown by mutagenesis that conserved amino acids in the HKD domains are important for both the catalytic activity and the association between the two halves of rPLD1. Furthermore, we found that rPLD1 could be modified by Ser/Thr phosphorylation. The modification occurred at the N-terminal half of the enzyme, however, the association of the N-terminal domain with the C-terminal domain was required for the modification. The phosphorylation of the enzyme was not required for its catalytic activity or response to PKCalpha and small G proteins in vitro, although the phosphorylated form of rPLD1 was localized exclusively in the crude membrane fraction. In addition, we found that the individually expressed N- and C-terminal fragments did not interact when mixed in vitro and were unable to reconstruct PLD activity under these conditions. It is concluded that the association of the N- and C-terminal halves of rPLD1 requires their co-expression in vivo and depends on conserved residues in the HKD domains. The association is also required for Ser/Thr phosphorylation of the enzyme.


Subject(s)
Brain/enzymology , Phospholipase D/chemistry , Phospholipase D/metabolism , Amino Acid Sequence , Animals , COS Cells , Cell Membrane/enzymology , Conserved Sequence , Cytosol/enzymology , Kinetics , Molecular Sequence Data , Mutagenesis, Site-Directed , Phospholipase D/genetics , Phosphorylation , Phosphoserine/metabolism , Phosphothreonine/metabolism , Rats , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Alignment , Transfection
11.
Ann N Y Acad Sci ; 905: 61-8, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10818442

ABSTRACT

Phospholipase D is an ubiquitous enzyme that hydrolyzes phosphatidylcholine to phosphatidic acid and choline. Its cellular actions are related to the production of phosphatidic acid and include alterations to cell growth, shape, and secretion. There are two mammalian phospholipase D genes whose products (PLD1 and PLD2) are alternatively spliced. Both forms have two highly conserved HKD motifs that are essential for catalysis and dimerization. PLD1 is regulated in vitro and in vivo by protein kinase C and small GTPases of the Rho and ARF families, whereas PLD2 shows a higher basal activity with little or no response to these proteins. The cellular locations and specific functions of the two PLD isoforms remain to be established.


Subject(s)
Phospholipase D/metabolism , Animals , Humans
12.
J Biol Chem ; 275(13): 9742-8, 2000 Mar 31.
Article in English | MEDLINE | ID: mdl-10734127

ABSTRACT

Several guanine nucleotide exchange factors for the Rho family of GTPases that induce activation by exchanging GDP for GTP have been identified. One of these is the tumor invasion gene product Tiam1, which acts on Rac1. In this study, we demonstrate that platelet-derived growth factor (PDGF) and lysophosphatidic acid induce the translocation of Tiam1 to the membrane fraction of NIH 3T3 fibroblasts in a time-dependent manner. Previously, we have shown that Tiam1 is phosphorylated by protein kinase C (PKC) and calcium/calmodulin kinase II (CaMK II) after stimulation with agonists. Here we show, by pretreatment of cells with kinase inhibitors, that CaMK II, but not PKC, is involved in the membrane translocation of Tiam1. Addition of the calcium ionophore ionomycin alone induced the translocation of Tiam1. However, the cell-permeable diacylglycerol oleoylacetylglycerol was without effect and did not enhance the effect of ionomycin. These data further indicated a role for CaMK II and not PKC. Inhibition of phosphoinositide 3-kinase by wortmannin had little effect on the translocation of Tiam1. The role of phosphorylation was further studied by comparing the phosphorylation pattern of Tiam1 in the membranes versus whole cell Tiam1. PDGF-induced phosphorylation of membrane-associated Tiam1 occurred more rapidly than that of the total Tiam1 pool, and CaMK II, but not PKC, played a significant role in this process. Furthermore, by using the p21-binding domain of PAK-3, we show that PDGF, but not lysophosphatidic acid, activates Rac1 in vivo and that this activation involves CaMK II and PKC, but not 3-phosphoinositides. Our results indicate that Tiam1 is translocated to and phosphorylated at membranes after agonist stimulation and that CaMK II, but not PKC, is involved in this process. Also, these kinases are involved in the activation of Rac in vivo.


Subject(s)
Guanine Nucleotide Exchange Factors/metabolism , Lysophospholipids/pharmacology , Platelet-Derived Growth Factor/pharmacology , Proteins/metabolism , 3T3 Cells , Animals , Benzylamines/pharmacology , Biological Transport , Calcium/pharmacology , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Diglycerides/pharmacology , Enzyme Inhibitors/pharmacology , Guanine Nucleotide Exchange Factors/agonists , Indoles/pharmacology , Mice , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Proteins/antagonists & inhibitors , Sulfonamides/pharmacology , T-Lymphoma Invasion and Metastasis-inducing Protein 1
13.
Cell Signal ; 12(1): 37-45, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10676846

ABSTRACT

Lysophosphatidic acid (LPA) and endothelin-1 (ET-1) activate phospholipase D (PLD) in many cell types. To see if phospholipase C-gamma1 plays a role, we used embryonic fibroblasts from mice in which the PLCgamma1 gene was disrupted. Surprisingly, the effect of LPA on inositol phosphate accumulation was increased in these PLCgamma1-/- cells, whereas that of ET-1 was completely abrogated. When PLD activity was measured, the response to LPA was also enhanced and the response to ET-1 lost in the PLCgamma1-/- cells. Treatment of these cells with ionomycin and oleoyl acetyl glycerol to mimic PLC stimulation restored PLD activity. Treatment of either PLCgamma1+/+ and PLCgamma1-/- cells with tyrosine kinase inhibitors did not inhibit LPA- or ET-1-induced PLD activity. Moreover, LPA and ET-1 treatment of PLCgamma1+/+ and PLCgamma1-/- cells did not cause tyrosine phosphorylation of PLC-gamma1 or PLC-gamma2. In summary, these results show that the altered PLD responses to LPA and ET-1 in PLCgamma1-/- are due to changes in PLC activity and do not involve tyrosine kinase activity.


Subject(s)
Fibroblasts/enzymology , Isoenzymes/genetics , Lysophospholipids/pharmacology , Phospholipase D/genetics , Phospholipase D/metabolism , Type C Phospholipases/genetics , Animals , Cell Line , Enzyme Activation , Gene Deletion , Gene Expression Regulation, Enzymologic , Isoenzymes/metabolism , Mice , Phospholipase C gamma , Signal Transduction/drug effects , Signal Transduction/genetics , Type C Phospholipases/metabolism
14.
J Biol Chem ; 274(51): 36609-15, 1999 Dec 17.
Article in English | MEDLINE | ID: mdl-10593962

ABSTRACT

Yeast two-hybrid screening of a human kidney cDNA library using the GTP-bound form of a class II ADP-ribosylation factor (ARF5) identified a novel ARF5-binding protein with a calculated molecular mass of 82.4 kDa, which was named arfophilin. Northern hybridization analysis showed high level arfophilin mRNA expression in human heart and skeletal muscle. Arfophilin bound only to the active, GTP-bound form of ARF5 and did not bind to GTP-ARF3, which is a class I ARF. The N terminus of ARF5 (1-17 amino acids) was essential for binding to arfophilin. The GTP-bound form of ARF5 with amino acid residues in the N terminus mutated to those in ARF4 (another class II ARF) also bound to arfophilin, suggesting it is a target protein for GTP-bound forms of class II ARFs. The binding site for ARF on arfophilin was localized to the C terminus (residues 612-756), which contains putative coiled-coil structures. Recombinant arfophilin overexpressed in CHO-K1 cells was localized in the cytosol and translocated to a membrane fraction in association with GTP-bound ARF5. ARF5 containing the N terminus of ARF3 did not promote translocation indicating that class II ARFs are specific carriers for arfophilin.


Subject(s)
ADP-Ribosylation Factors/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Proteins/genetics , Proteins/metabolism , Amino Acid Sequence , Animals , CHO Cells , Cloning, Molecular , Cricetinae , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , GTP-Binding Proteins/metabolism , Humans , Molecular Sequence Data , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Sequence Alignment
15.
FEBS Lett ; 454(1-2): 85-9, 1999 Jul 02.
Article in English | MEDLINE | ID: mdl-10413101

ABSTRACT

ADP-ribosylation factors (ARFs) regulate coatomer assembly on the Golgi as well as recruitment of clathrin adapter proteins and are therefore involved in vesicle budding from the Golgi and vesicular transport. They are also regulators of phospholipase D (PLD) activity. Arfaptin 1 is an ARF binding protein that inhibits PLD activation, vesicular trafficking and secretion. In the present report, we show that arfaptin 1 interacts with 'high speed' membranes independently of ARF. However, addition of myristoylated ARF3 (myrARF3) increases the association of arfaptin 1 with the membranes, suggesting that arfaptin 1 and ARF form a complex on the Golgi. Utilizing several deletion mutants of arfaptin 1 it is shown that the association of arfaptin 1 with myrARF3 is mediated via two binding sites on arfaptin 1. These two domains are needed for arfaptin 1 inhibition of PLD activation by myrARF3 in vitro.


Subject(s)
Adaptor Proteins, Signal Transducing , Carrier Proteins/pharmacology , GTP-Binding Proteins/metabolism , Phospholipase D/antagonists & inhibitors , ADP-Ribosylation Factors , Animals , Dose-Response Relationship, Drug , Escherichia coli/metabolism , Glutathione Transferase/metabolism , Golgi Apparatus/drug effects , Liver/metabolism , Rats , Recombinant Fusion Proteins/pharmacology , Tumor Cells, Cultured
16.
Biochim Biophys Acta ; 1439(2): 121-33, 1999 Jul 30.
Article in English | MEDLINE | ID: mdl-10425390

ABSTRACT

Phospholipase D (PLD) is a widely distributed enzyme that is under elaborate control by hormones, neurotransmitters, growth factors and cytokines in mammalian cells. Protein kinase C (PKC) plays a major role in the regulation of the PLD1 isozyme through interaction with its N-terminus. PKC activates this isozyme by a non-phosphorylation mechanism in vitro, but phosphorylation plays a role in the action of PKC on the enzyme in vivo. Although PLD1 can be phosphorylated by PKC in vitro, it is unclear that this occurs in vivo. Small GTPases of the ADP-ribosylation factor (ARF) and Rho families directly activate PLD1 in vitro and there is evidence that Rho proteins are involved in agonist regulation of PLD1 in vivo. ARF proteins stimulate PLD activity in the Golgi apparatus, but the role of these proteins in agonist regulation of the enzyme is less clear. PLD1 undergoes tyrosine phosphorylation in response to H(2)O(2) treatment of cells. The functional consequence of this phosphorylation and soluble tyrosine kinase(s) involved are presently unknown.


Subject(s)
ADP-Ribosylation Factors , Membrane Proteins , Phospholipase D/metabolism , Animals , Calcium/physiology , Cell Line , Ceramides/metabolism , Enzyme Activation , GTP Phosphohydrolases/physiology , GTP-Binding Proteins/physiology , Humans , Phosphatidylinositols/metabolism , Protein Kinase C/physiology , Protein-Tyrosine Kinases/physiology
17.
J Biol Chem ; 274(18): 12753-8, 1999 Apr 30.
Article in English | MEDLINE | ID: mdl-10212259

ABSTRACT

A number of guanine nucleotide exchange factors have been identified that activate Rho family GTPases, by promoting the binding of GTP to these proteins. We have recently demonstrated that lysophosphatidic acid and several other agonists stimulate phosphorylation of the Rac1-specific exchange factor Tiam1 in Swiss 3T3 fibroblasts, and that protein kinase C is involved in Tiam1 phosphorylation (Fleming, I. N., Elliott, C. M., Collard, J. G., and Exton, J. H. (1997) J. Biol. Chem. 272, 33105-33110). We now show, through manipulation of intracellular [Ca2+] and the use of protein kinase inhibitors, that both protein kinase Calpha and Ca2+/calmodulin-dependent protein kinase II are involved in the phosphorylation of Tiam1 in vivo. Furthermore, we show that Ca2+/calmodulin-dependent protein kinase II phosphorylates Tiam1 in vitro, producing an electrophoretic retardation on SDS-polyacrylamide gel electrophoresis. Significantly, phosphorylation of Tiam1 by Ca2+/calmodulin-dependent protein kinase II, but not by protein kinase C, enhanced its nucleotide exchange activity toward Rac1, by approximately 2-fold. Furthermore, Tiam1 was preferentially dephosphorylated by protein phosphatase 1 in vitro, and treatment with this phosphatase abolished the Ca2+/calmodulin-dependent protein kinase II activation of Tiam1. These data demonstrate that protein kinase Calpha and Ca2+/calmodulin-dependent protein kinase II phosphorylate Tiam1 in vivo, and that the latter kinase plays a key role in regulating the activity of this exchange factor in vitro.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Proteins/metabolism , 3T3 Cells , Animals , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Guanine Nucleotide Exchange Factors , Guanosine Diphosphate/metabolism , Guanosine Triphosphate/metabolism , Isoenzymes/metabolism , Mice , Phosphoprotein Phosphatases/metabolism , Phosphorylation , Protein Kinase C/metabolism , Protein Phosphatase 1 , T-Lymphoma Invasion and Metastasis-inducing Protein 1
18.
FEBS Lett ; 443(2): 197-200, 1999 Jan 25.
Article in English | MEDLINE | ID: mdl-9989604

ABSTRACT

Class I ADP-ribosylation factors (ARFs) are essential for coatomer and clathrin coat assembly and vesicular transport in the Golgi apparatus. However, little is known about the in vivo regulation of ARF actions. Recently we cloned arfaptin 1, a 39 kDa protein that binds active, GTPgammaS-liganded ARF and translocates with it to Golgi membranes. Here we show that phorbol ester-stimulated phospholipase D (PLD) activity is inhibited in arfaptin 1-overexpressing NIH 3T3 cells and that arfaptin 1 inhibits ARF activation of Golgi-associated PLD. Since PLD activity is thought to play a role in regulating vesicular transport in the secretory pathway, we determined the rate of glycosylation of vesicular stomatitis virus glycoprotein as a measure of protein transport from the endoplasmic reticulum through the Golgi apparatus. Arfaptin 1 overexpression was found to decrease the rate of this reaction approximately two-fold. These data suggest that arfaptin 1 is a regulator of ARF action in the Golgi apparatus.


Subject(s)
Adaptor Proteins, Signal Transducing , Carrier Proteins/metabolism , Endoplasmic Reticulum/metabolism , Golgi Apparatus/metabolism , Membrane Glycoproteins , Phospholipase D/antagonists & inhibitors , Proteins/metabolism , 3T3 Cells , ADP-Ribosylation Factors , Animals , Biological Transport , Enzyme Activation , GTP-Binding Proteins/antagonists & inhibitors , Mice , Tetradecanoylphorbol Acetate/antagonists & inhibitors , Tetradecanoylphorbol Acetate/pharmacology , Viral Envelope Proteins/metabolism
19.
J Biol Chem ; 274(2): 735-8, 1999 Jan 08.
Article in English | MEDLINE | ID: mdl-9873009

ABSTRACT

Phospholipase D (PLD) has been implicated in vesicle trafficking in the Golgi and hence secretion. In this study, we show that the secretion of matrix metalloproteinase-9 (MMP-9) from HT 1080 human fibrosarcoma cells was stimulated by phorbol 12-myristate 13-acetate in a time- and dose-dependent manner that involved protein kinase C. The phorbol ester also increased PLD activity in the cells. Evidence that PLD was involved in the stimulation of MMP-9 secretion was provided by the observations that the secretion of MMP-9 was stimulated by the introduction of short-chain phosphatidic acid (PA) into the growth medium and that inhibition of PA production by 1-propanol inhibited secretion. Using a short-chain diacylglycerol we excluded the possibility that MMP-9 secretion was induced by diacylglycerol formed from PA by phosphatidic acid phosphatase. Furthermore, propranolol, an inhibitor of this enzyme, had no effect on secretion induced by either phorbol 12-myristate 13-acetate or PA. The data presented here indicate that activation of protein kinase C increases MMP-9 secretion in HT 1080 cells and implicate PLD and PA formation in the effect.


Subject(s)
Collagenases/metabolism , Fibrosarcoma/enzymology , Phospholipase D/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Enzyme Activation , Fibrosarcoma/pathology , Golgi Apparatus/enzymology , Humans , Matrix Metalloproteinase 9 , Phosphatidate Phosphatase/metabolism , Phosphatidic Acids/pharmacology , Protein Kinase C/metabolism , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...